In this Multidisciplinary Roundtable discussion, James Matera, DO, speaks with nephrologist Wayne Kotzker, MD, primary care physician Maria Ciminelli, MD, cardiologist Lance Berger, MD, and nutritionist Jamie Miller, RD, about the role of the multidisciplinary approach in the management of patients with chronic kidney disease (CKD), including referring a patient to a specialist, ensuring risk reduction and slowing the progression of end-stage renal disease, and cardiovascular risk factors in patients with CKD.
In this podcast, James Matera, DO, speaks about a patient case presentation of a 41-year-old man with a recurrence of minimal change disease and an incidental finding of papillary renal cell carcinoma on...
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the clinical challenges and strategies in managing a patient with severe tophaceous gout and stage 3 chronic kidney disease, including urate-lowering...
Resham Khan, MD 1,2, Mohammad Zafar, MD 1,2, Bianca Leuzzi, MD 1,2
Resham Khan, MD 1,2, Mohammad Zafar, MD 1,2, Bianca Leuzzi, MD 1,2
The presenting patient is a 76-year-old woman with a history of duodenal ulcers status post perforation, subsequent repair via ex-laparotomy, multiple gastrointestinal bleeds, chronic anemia, and chronic...
Utilizing appropriate markers of nutritional status in individuals with chronic kidney disease is essential to providing appropriate care. Do you know which biomarker measurement can be used to predict...
Patients with chronic kidney disease (CKD) are encouraged to maintain a diet that helps manage the disease. Do you know the recommended amount of calcium a person with CKD should ingest every day?
Controversies exist in the management of chronic kidney disease and comorbidities. Do you think the currently available clinical practice guidelines sufficiently address these controversies?
Do you know how long abnormal kidney structure or function should be present before a patient is diagnosed with chronic kidney disease? Test your knowledge with our latest pop quiz!
In this podcast, James Matera, DO, speaks about a patient case presentation of a 41-year-old man with a recurrence of minimal change disease and an incidental finding of papillary renal cell carcinoma on...
In this video, Monica Richey, MSN, ANP-BC/GNP, discusses the clinical challenges and strategies in managing a patient with severe tophaceous gout and stage 3 chronic kidney disease, including urate-lowering...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
In this video, Eric Gottlieb, MD, MS, discusses the use of cystatin C vs creatinine to estimate glomerular filtration rate in diverse patient populations and how the use of cystatin C to estimate GFR can...
